FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1820005831> ?p ?o ?g. }

• W1820005831 endingPage "10657" @default.
• W1820005831 startingPage "10646" @default.
• W1820005831 abstract "// Ya-Wen Wang 1, * , Xu Chen 1, * , Ji-Wei Gao 1 , Hui Zhang 1 , Ran-Ran Ma 1 , Zu-Hua Gao 1, 2 , Peng Gao 1 1 Department of Pathology, School of Medicine, Shandong University, Jinan, P.R. China 2 Department of Pathology, McGill University, Montreal, Canada * These authors have contributed equally to this work Correspondence to: Peng Gao, e-mail: gaopeng@sdu.edu.cn Keywords: gastric cancer, CREB1, metastasis, prognosis, miRNA Received: December 05, 2014      Accepted: February 17, 2015      Published: March 18, 2015 ABSTRACT cAMP responsive element binding protein 1 (CREB1) has been reported to be implicated in tumor development and progression of human cancers. However, the clinical significance and regulatory mechanisms of CREB1 expression in gastric cancer remain largely unknown. In the present study, immunohistochemistry was performed to detect the expression of CREB1 protein in 185 primary gastric cancer tissues, 50 secondary lymph node metastatic foci and 50 nontumorous gastric tissues. A prognostic model combining CREB1 expression with TNM tumor stage was constructed by logistic regression analysis. Regulation of CREB1 by miRNAs was investigated by luciferase reporter assay and Western blot. It was shown that CREB1 was highly expressed and correlated with lymph node metastasis, distant metastasis and tumor stage and poor outcome in gastric cancer. The prognostic model was proven to be an independent prognosis predictor and performed better than CREB1 or tumor stage alone. CREB1 was identified as a direct target of miR-27b and miR-200b, and down-regulated by miR-27b/miR-200b. We conclude that CREB1 is a promising biomarker to predict tumor metastasis and patient outcome in gastric cancer, and the miR-27b/miR-200b-CREB1 pathway may serve as a potential molecular target for the treatment of gastric cancer." @default.
• W1820005831 created "2016-06-24" @default.
• W1820005831 creator A5000218462 @default.
• W1820005831 creator A5003759585 @default.
• W1820005831 creator A5033323312 @default.
• W1820005831 creator A5051738549 @default.
• W1820005831 creator A5057948519 @default.
• W1820005831 creator A5072679494 @default.
• W1820005831 creator A5077233021 @default.
• W1820005831 date "2015-03-18" @default.
• W1820005831 modified "2023-10-18" @default.
• W1820005831 title "High expression of cAMP responsive element binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer" @default.
• W1820005831 cites W1493066653 @default.
• W1820005831 cites W1964586745 @default.
• W1820005831 cites W1986583933 @default.
• W1820005831 cites W1989940919 @default.
• W1820005831 cites W2002995168 @default.
• W1820005831 cites W2008775304 @default.
• W1820005831 cites W2009679953 @default.
• W1820005831 cites W2013336412 @default.
• W1820005831 cites W2015198866 @default.
• W1820005831 cites W2017632843 @default.
• W1820005831 cites W2018263869 @default.
• W1820005831 cites W2020830322 @default.
• W1820005831 cites W2023033116 @default.
• W1820005831 cites W2027592666 @default.
• W1820005831 cites W2029549060 @default.
• W1820005831 cites W2040182688 @default.
• W1820005831 cites W2045034903 @default.
• W1820005831 cites W2058852130 @default.
• W1820005831 cites W2060208186 @default.
• W1820005831 cites W2076820222 @default.
• W1820005831 cites W2086985854 @default.
• W1820005831 cites W2088359631 @default.
• W1820005831 cites W2089264706 @default.
• W1820005831 cites W2090731066 @default.
• W1820005831 cites W2092693530 @default.
• W1820005831 cites W2093921289 @default.
• W1820005831 cites W2098100072 @default.
• W1820005831 cites W2101117089 @default.
• W1820005831 cites W2111534956 @default.
• W1820005831 cites W2119047973 @default.
• W1820005831 cites W2137385309 @default.
• W1820005831 cites W2151609603 @default.
• W1820005831 cites W2153234291 @default.
• W1820005831 cites W2153747194 @default.
• W1820005831 cites W2159586009 @default.
• W1820005831 cites W2161636433 @default.
• W1820005831 cites W2170873358 @default.
• W1820005831 cites W2597632520 @default.
• W1820005831 doi "https://doi.org/10.18632/oncotarget.3392" @default.
• W1820005831 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4496382" @default.
• W1820005831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25825983" @default.
• W1820005831 hasPublicationYear "2015" @default.
• W1820005831 type Work @default.
• W1820005831 sameAs 1820005831 @default.
• W1820005831 citedByCount "44" @default.
• W1820005831 countsByYear W18200058312015 @default.
• W1820005831 countsByYear W18200058312016 @default.
• W1820005831 countsByYear W18200058312017 @default.
• W1820005831 countsByYear W18200058312018 @default.
• W1820005831 countsByYear W18200058312019 @default.
• W1820005831 countsByYear W18200058312020 @default.
• W1820005831 countsByYear W18200058312021 @default.
• W1820005831 countsByYear W18200058312022 @default.
• W1820005831 countsByYear W18200058312023 @default.
• W1820005831 crossrefType "journal-article" @default.
• W1820005831 hasAuthorship W1820005831A5000218462 @default.
• W1820005831 hasAuthorship W1820005831A5003759585 @default.
• W1820005831 hasAuthorship W1820005831A5033323312 @default.
• W1820005831 hasAuthorship W1820005831A5051738549 @default.
• W1820005831 hasAuthorship W1820005831A5057948519 @default.
• W1820005831 hasAuthorship W1820005831A5072679494 @default.
• W1820005831 hasAuthorship W1820005831A5077233021 @default.
• W1820005831 hasBestOaLocation W18200058311 @default.
• W1820005831 hasConcept C104317684 @default.
• W1820005831 hasConcept C121608353 @default.
• W1820005831 hasConcept C126322002 @default.
• W1820005831 hasConcept C143998085 @default.
• W1820005831 hasConcept C146357865 @default.
• W1820005831 hasConcept C151730666 @default.
• W1820005831 hasConcept C1629964 @default.
• W1820005831 hasConcept C199172495 @default.
• W1820005831 hasConcept C204232928 @default.
• W1820005831 hasConcept C2776415932 @default.
• W1820005831 hasConcept C2779013556 @default.
• W1820005831 hasConcept C502942594 @default.
• W1820005831 hasConcept C55493867 @default.
• W1820005831 hasConcept C71924100 @default.
• W1820005831 hasConcept C86339819 @default.
• W1820005831 hasConcept C86803240 @default.
• W1820005831 hasConceptScore W1820005831C104317684 @default.
• W1820005831 hasConceptScore W1820005831C121608353 @default.
• W1820005831 hasConceptScore W1820005831C126322002 @default.
• W1820005831 hasConceptScore W1820005831C143998085 @default.
• W1820005831 hasConceptScore W1820005831C146357865 @default.
• W1820005831 hasConceptScore W1820005831C151730666 @default.
• W1820005831 hasConceptScore W1820005831C1629964 @default.

• next